Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Aquaculture Vaccines Market

Aquaculture Vaccines Market Trends

Report ID: GMI3323
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Aquaculture Vaccines Market Trends

Increasing aquaculture production will have a significant impact on demand for aquaculture vaccines.

High growth in aquaculture activities is attributed to growing demand for seafood and canned seafood products. Sea food is rich source of micronutrients such as zinc, iron, and vitamin A along with protein that leads to high demand for seafood.
For instance, as per the 2024 edition of The State of World Fisheries and Aquaculture (SOFIA), global fisheries and aquaculture production in 2022 surged to 223.2 million tonnes, a 4.4 percent increase from the year 2020. The report also stated that, in the period 1990–2020, total world aquaculture expanded by 609 percent in annual output with an average growth rate of 6.7 percent per year.
Thus, with increase in aquaculture production to meet the growing demand, the need for the protection of farmed fishes from bacterial and virus infection is also rising.
Additionally, increasing demand for safe and healthy seafood is one of the major factors propelling demand for aquaculture vaccines across the forecast timeframe.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global aquaculture vaccines industry was valued at USD 407.4 million in 2024 and is estimated to grow at a CAGR of 8% from 2025 to 2034, driven by increasing global demand for seafood and sustainable aquaculture practices.

The inactivated vaccine segment was valued at USD 302.6 million in 2024, holding a significant market share due to its proven safety and efficacy in protecting fish populations against various bacterial and viral diseases.

The European region dominates the aquaculture vaccines industry, with Norway's market valued at USD 85.4 million in 2024, driven by its robust aquaculture industry, particularly in salmon farming.

Key players in the sector include CIBA, HIPRA, Kyoto Biken Laboratories, Kemin Industries, Kyoritsuseiyaku Corporation, Merck Animal Health (a division of Merck & Co.), Nisseiken, Phibro Animal Health Corporation, Tecnovax, Virbac, and Veterquimica.